Navigation Links
Trial finds more support for universal HIV screening in emergency departments

CINCINNATIScreening everyone for HIV in the emergency department may be superior to testing only those with apparent risk, when trying to identify patients with undiagnosed HIV infection, according to a new results by researchers at the University of Cincinnati (UC).

Though the U.S. Centers for Disease Control and Prevention and national research organizations have recommended universal HIV screening, lead author Michael Lyons, MD, says there is still disagreement among physicians on how to implement screening in the nation's already busy emergency departments. Lyons, an assistant professor of emergency medicine, directs UC's HIV Early Intervention Program, which provides HIV screenings in the University of Cincinnati Medical Center emergency department and in community-based settings around Cincinnati.

Proponents of targeted testingwho argue that it is more beneficial to perform fewer tests but have more tests be positivesay limiting HIV screening to those with identified risk reduces the number of tests emergency departments have to perform, saving time and cost.

Opponents say that targeting only those at risk is insufficient because it misses cases. However, Lyons says, previous trials do not delineate whether cases have been missed because testing criteria are limited or because screening was not applied to enough patients to provide clear results.

"More selective HIV screening is thought to miss more cases, but there have never been well-designed comparison studies on which targeting criteria are best," he says, "so with this study, we hypothesized that by using very broad criteria and applying sufficient resources to test everyone who met those criteria, we could detect nearly as many cases as universal screening but still use many fewer tests."

In the randomized trial, patients receiving universal screening were offered an HIV test regardless of their risk factors. For patients randomized to targeted screening, researchers intentionally set very broad parameters, offering HIV testing for any possible risk indicator that could be identified, many more criteria than are usually considered.

There were 9,572 patients approached to offer screening. Contrary to expectations, targeted screening did not diagnose nearly as many patients and did not require that many fewer tests.

For patients screened universally, approximately 40 percent consented to testing and six patients were newly diagnosed.

For patients receiving targeted screening, 47 percent consented and three patients were newly diagnosed. Overall, Lyons says the number of tests saved by targeting led to similar reductions in new cases detected.

"This shows that this method of targeted screening, using with broadest possible selection criteria, offers no important advantage over universal screening," says Lyons. "We will need other studies to discover whether some other method of selecting patients for HIV screening could succeed, where this method did not, in limiting testing while still detecting most cases.

The team's results, "Randomized Comparison of Universal and Targeted HIV Screening in the Emergency Department," are published online ahead of print in the Journal of Acquired Immune Deficiency Syndromes.


Contact: Katy Cosse
University of Cincinnati Academic Health Center

Related medicine news :

1. Tumor cell vaccination trial to promote anti-leukemia responses
2. Vaginal Mesh Lawsuit Bellwether Trial Is Underway As Jury Selection Is Finalized, Reports Wright & Schulte
3. Several Korein Tillery Lawyers Nominated as Finalists for the Public Justice “Trial Lawyer of the Year” Award
4. Apixaban in atrial fibrillation: Indications of considerable added benefit
5. Mesothelioma Victims Center Now Focuses On Ensuring Industrial Workers Diagnosed With Mesothelioma Have Instant Access To The Nations Most Skilled Mesothelioima Attorneys
6. Block O'Toole & Murphy, LLP Personal Injury Trial Lawyers Take $2,270,000 Verdict In Brooklyn Motor Vehicle Accident Case
7. NuvaRing Bellwether Trial Scheduled: Now, AttorneyOne Can Provide Advice
8. Mesh Lawsuit Trial: Bernstein Liebhard LLP Notes Selection of Jury in Federal C.R. Bard Vaginal Mesh Lawsuit Trial
9. New poll shows minority populations support clinical trials to improve health of others
10. Triple Anti-Oxidant Liver Formula, a Proactive Approach to Dealing with Environmental Toxins, is Now Available for a Complimentary Trial
11. Doyle Raizner Pradaxa Case Chosen for Bellwether Early Trial Consideration
Post Your Comments:
(Date:12/1/2015)... , ... December 01, 2015 , ... Lutronic, a leading ... Clarity, the latest addition to the devices for sale in the United States. ... Alexandrite and long-pulsed 1064 nm Nd:YAG lasers, into a single platform that is easy ...
(Date:12/1/2015)... ... 01, 2015 , ... PYA’s latest white paper, “ PYA ... main “pain point” for merging or aligning healthcare provider organizations—when mergers and other ... This quick-read guidance suggests that failing to recognize the power of an ...
(Date:12/1/2015)... ... December 01, 2015 , ... PartnerTech , ... membership and leadership since 2008. Gary Bruce, President of PartnerTech North America, currently ... spent a significant amount of time in Sweden since joining PartnerTech based in ...
(Date:12/1/2015)... ... December 01, 2015 , ... Nurotron Biotechnology Co., Ltd., maker ... order to date. , The order will be from the China Disabled Persons’ ... Implant System is an effective solution for children and adults suffering from severe ...
(Date:12/1/2015)... Charlotte, NC (PRWEB) , ... December 01, 2015 ... ... NHS Foundation Trust on receiving the 2015 HSJ Acute Sector Innovation Award on ... of improving the patient care experience, and propose exciting enhancements to the medical ...
Breaking Medicine News(10 mins):
(Date:12/1/2015)... BOSTON , Dec. 1, 2015  The ... (HCOs) to develop shared care plans that help ... These care plans will be digitally enabled, incorporate ... unique needs and desires. They will also allow ... a patient,s health journey is optimal. That is ...
(Date:12/1/2015)... Germany , December 1, 2015 /PRNewswire/ ... leading global manufacturer of eye and gaze tracking solutions, ... SMI remote eye trackers as a component of its ... concussions, eye sight, and medical and performance issues in ... part of SMI,s mass-market-ready eye tracking platform, which is ...
(Date:12/1/2015)... THE WOODLANDS, Texas , Dec. 1, ... LXRX )  announced today that top-line data ... results of telotristat etiprate in treating carcinoid ... tumors consistent with the clinical benefit observed ... study was designed as a companion to ...
Breaking Medicine Technology: